MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-06-2025
BioLife Solutions Cash and Cash Equivalents 2011-2026 | BLFS
Annual Cash and Cash Equivalents BioLife Solutions
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 95.4 M | 27.9 M | 19.4 M | 69.9 M | 90.4 M | 6.45 M | 30.7 M | 6.66 M | 1.41 M | 2.17 M | 2.54 M | 156 K | 196 K | 16.9 K |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 95.4 M | 16.9 K | 25.2 M |
Quarterly Cash and Cash Equivalents BioLife Solutions
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 29.5 M | 31.9 M | 66.9 M | 95.4 M | 24.2 M | 22 M | 29.7 M | 33.3 M | 19.3 M | 21.4 M | 19.1 M | 19.4 M | 27.1 M | 24 M | 59.5 M | 69.9 M | 75.1 M | 76.2 M | 89 M | 90.4 M | 90.4 M | 90.4 M | 90.4 M | 6.45 M | 6.45 M | 6.45 M | 6.45 M | 30.7 M | 30.7 M | 30.7 M | 30.7 M | 6.66 M | 6.66 M | 6.66 M | 6.66 M | 1.41 M | 1.41 M | 1.41 M | 1.41 M | 2.17 M | 2.17 M | 2.17 M | 2.17 M | 2.54 M | 2.54 M | 2.54 M | 2.54 M | 156 K | 156 K | 156 K | 156 K | 196 K | 196 K | 196 K | 196 K | 16.9 K | 16.9 K | 16.9 K | 16.9 K |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 95.4 M | 16.9 K | 23.7 M |
Cash and Cash Equivalents of other stocks in the Medical instruments industry
| Issuer | Cash and Cash Equivalents | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Atrion Corporation
ATRI
|
3.56 M | - | - | $ 810 M |  USA |
 |
Baxter International
BAX
|
1.76 B | $ 20.1 | 1.85 % | $ 10.3 B | USA |
 |
ICU Medical
ICUI
|
309 M | $ 148.85 | -0.79 % | $ 3.63 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
6.49 M | $ 8.57 | 2.15 % | $ 173 M | USA |
 |
Alcon
ALC
|
1.68 B | $ 81.03 | -0.12 % | $ 40.4 B |  Schweiz |
 |
Repro Med Systems
KRMD
|
11.5 M | $ 5.39 | -1.1 % | $ 246 M | USA |
 |
AtriCure
ATRC
|
123 M | $ 36.9 | -0.14 % | $ 1.73 B | USA |
 |
Haemonetics Corporation
HAE
|
307 M | $ 66.55 | 0.88 % | $ 3.35 B | USA |
 |
electroCore
ECOR
|
10.3 M | $ 6.6 | -7.04 % | $ 36.4 K | USA |
 |
AngioDynamics
ANGO
|
55.9 M | $ 10.3 | 3.21 % | $ 421 M | USA |
 |
InfuSystem Holdings
INFU
|
165 K | $ 8.27 | 2.73 % | $ 171 M | USA |
 |
OraSure Technologies
OSUR
|
268 M | $ 2.78 | -0.54 % | $ 207 M | USA |
 |
The Cooper Companies
COO
|
111 M | $ 81.34 | 1.21 % | $ 16.2 B | USA |
 |
Masimo Corporation
MASI
|
178 M | $ 137.49 | 0.91 % | $ 7.33 B | USA |
 |
Harvard Bioscience
HBIO
|
4.28 M | $ 0.5 | -6.73 % | $ 21.2 M | USA |
 |
Glaukos Corporation
GKOS
|
93.5 M | $ 119.29 | 0.28 % | $ 5.78 B | USA |
 |
Merit Medical Systems
MMSI
|
377 M | $ 80.93 | 0.85 % | $ 4.71 B | USA |
 |
Isoray
ISR
|
61.6 M | - | 0.03 % | $ 108 M | USA |
 |
iRhythm Technologies
IRTC
|
420 M | $ 154.21 | 3.5 % | $ 4.81 B | USA |
 |
LeMaitre Vascular
LMAT
|
25.6 M | $ 84.97 | 1.32 % | $ 1.91 B | USA |
 |
STERIS plc
STE
|
172 M | $ 261.9 | 0.02 % | $ 25.8 B | USA |
 |
Intuitive Surgical
ISRG
|
2.03 B | $ 505.17 | -0.47 % | $ 179 B | USA |
 |
NeuroMetrix
NURO
|
1.43 M | - | 5.05 % | $ 9.02 M | USA |
 |
Microbot Medical
MBOT
|
2.47 M | $ 1.81 | -2.96 % | $ 18.5 M |  Israel |
 |
Utah Medical Products
UTMD
|
92.9 M | $ 61.21 | -0.71 % | $ 222 M | USA |
 |
Nephros
NEPH
|
4.31 M | $ 4.35 | -0.91 % | $ 45.2 M | USA |
 |
Milestone Scientific
MLSS
|
3.26 M | $ 0.29 | -2.67 % | $ 23.1 M | USA |
 |
Envista Holdings Corporation
NVST
|
1.07 B | $ 23.4 | 0.13 % | $ 4.03 B | USA |
 |
Pro-Dex
PDEX
|
419 K | $ 38.77 | -1.61 % | $ 127 M | USA |
 |
Predictive Oncology
POAI
|
735 K | - | - | $ 31.1 M | USA |
 |
Pulse Biosciences
PLSE
|
44.4 M | $ 13.76 | 0.99 % | $ 661 M | USA |
 |
Becton, Dickinson and Company
BDX
|
641 M | $ 203.2 | 1.05 % | $ 58.5 B | USA |
 |
Repligen Corporation
RGEN
|
751 M | $ 150.44 | -3.8 % | $ 8.38 M | USA |
 |
ResMed
RMD
|
274 M | $ 256.15 | -0.57 % | $ 37.4 B | USA |
 |
Stereotaxis
STXS
|
19.8 M | $ 2.21 | -5.36 % | $ 178 M | USA |
 |
Retractable Technologies
RVP
|
4.24 M | $ 0.7 | -1.03 % | $ 21 M | USA |
 |
STAAR Surgical Company
STAA
|
144 M | $ 18.9 | -0.24 % | $ 928 M | USA |
 |
Teleflex Incorporated
TFX
|
290 M | $ 104.44 | -0.96 % | $ 4.89 B | USA |
 |
West Pharmaceutical Services
WST
|
485 M | $ 231.57 | -0.4 % | $ 16.9 B | USA |
 |
DENTSPLY SIRONA
XRAY
|
272 M | $ 12.47 | 1.63 % | $ 2.53 B | USA |